Register for SOSV’s HAX demo days in San Francisco (4/29) and Newark (5/6)

Recent news

Type
Trends
Programs
Category
Post Feb 28, 2025

Breaking Out of the Agtech Echo Chamber: SOSV GP Po Bronson’s Vision

Po Bronson, General Partner at SOSV and Managing Director of IndieBio, was profiled by AgTechNavigator and shared his vision on how to break out of the Agtech echo chamber.

Post Feb 27, 2025

What Now? From the IRA to “Drill, Baby, Drill” – SOSV Deep Tech LIVE Premieres with Princeton’s Dr. Jesse Jenkins

We’re kicking off something big—SOSV Deep Tech LIVE, our brand-new video podcast series, where we explore the frontiers of Deep Tech with the world’s leading technologists, founders, and researchers.

TechCrunch Feb 26, 2025

Mitico raises $4.3M seed round to revolutionize CO₂ capture with ‘prehistoric chemistry’

We’re thrilled to announce that Mitico, a graduate from our HAX hard tech program, has secured a $4.3 million seed round, led by Exergon with participation from AP Ventures, Deepbright Ventures, Freeflow Ventures, Halliburton Labs, the Alliance for SoCal Innovation, SOSV, and W. L. Gore & Associates’ ventures team. This funding will accelerate their innovative […]

Post Feb 21, 2025

Announcing IndieBio SF’s VC-Founder Meetings + Demo Day  – Week of March 17, 2025

Investors! Join IndieBio in San Francisco during the week of March 17, 2025 for Demo Day featuring 8 new companies and 3 alumni companies.

TechCrunch Feb 20, 2025

Hyperlume Raises $12.5M Seed Round to Solve for Latency and Energy Consumption in Data Centers

Ottawa-based Hyperlume, a 2023 graduate of SOSV’s HAX program, has secured a $12.5 million seed funding round to advance its innovative optical interconnect solutions for AI data centers and high-performance computing systems. The round was led by BDC Capital’s Deep Tech Venture Fund and ArcTern Ventures, with participation from MUUS Climate Partners, Intel Capital, and SOSV 

TechCrunch Feb 18, 2025

Continuous Hormone Monitoring Startup Level Zero Health Raises $6.9M Pre-seed Round

Level Zero Health, a recent graduate from SOSV’s HAX hard tech program, has just secured $6.9M in a pre-seed funding round of $6.9 million led by European VC, redalpine, HAX (SOSV), Entrepreneur First (EF), and industry experts.

Post Feb 13, 2025

IndieBio NY’s Demo Day Kickoff Video

SOSV’s IndieBio NY just held a demo day at its offices in Manhattan. Fifteen spectacular deep tech founders tackling human and planetary health took the stage in front of a packed audience of investors. The IndieBio NY team made this terrific video to kick off the event and introduce the main deep tech themes of […]

Post Feb 12, 2025

Meet Deborah Zajac, SOSV and IndieBio NY’s new General Partner

Introducing Deborah Zajac, SOSV’s newest general partner and member of the IndieBio NY team.

Ten63 Therapeutics co-founders
Founder Stories Feb 07, 2025

How Ten63 turned an academic project into an AI platform for drugging “undruggable” cancers

Bruce Donald, Marcel Frenkel and Mark Hallen are analyzing over 19,290,123 compounds per second at quantum accuracies to develop drugs to previously incurable cancers.

Forbes Feb 04, 2025

Oxyle has raised $16M to rid water supplies of Forever Chemicals (PFAS)

Zurich-based Oxyle recently raised a $16M seed round led by 360 Ventures with participation from Axeleo Capital, Founderful and SOSV, according to a report in Forbes. Water supplies around the world are contaminated with “Forever Chemicals,” or the 10,000 perfluoroalkyl and polyfluoroalkyl substances known by the acronym PFAS. They are linked to a sharp increases […]